Our Research Publications

Updated August 2024

Title Authors Year Journal Link to Article Intended Audience Purpose
Vaccine-induced immune thrombotic thrombocytopenia presenting with normal platelet count Page D, Zhu N, Sawler D, Sun HW, Turley E, Pai M, Wu C 2021 Res Pract Thromb Haemost View Researchers Clinical research
Teaching bone marrow procedures at pelvic and sternal sites: a high fidelity anatomy simulation Heather Vander M, Laureano M, Hu G, Lim W, Ross C, Wainman B, Zeller MP 2021 Can Med Educ J View Health care providers Benchmarking and standard setting
Chaptire 16: Don autologue préopératoire Foster T, Yan M 2021 Guide de la pratique transfusionnelle View Health care providers Benchmarking and standard setting
External qualification of the Web-Accessible Population Pharmacokinetic Service-Hemophilia (WAPPS-Hemo) models for octocog alfa using real patient data Chelle P, Hajducek D, Mahdi M, Young S, Iorio A, Silvertown J, Edginton A 2021 Res Pract Thromb Haemost View Researchers New or improved product or process
Anti-inflammatory activity of CD44 antibodies in murine immune thrombocytopenia is mediated by Fc? receptor inhibition Norris PAA, Kaur G, Khan R, Zhu G, Ni H, Lazarus AH 2021 Blood View Researchers Basic research
Circular of information for the use of human blood components: Hematopoietic Progenitor Cells (HPC), Cord Blood Jenkins C 2021 Blood.ca website Health care providers Benchmarking and standard setting
FAQ: Canadian Blood Services Platelet Bacterial Testing Khandelwal A, Ramirez-Arcos S, Bigham M 2021 Blood.ca website View Health care providers Other
Platelet-activating immune complexes identified in critically ill COVID-19 patients suspected of heparin-induced thrombocytopenia Nazy I, Jevtic SD, Moore JC, Huynh A, Smith JW, Kelton JG, Arnold DM 2021 J Thromb Haemost View Health care providers Clinical research
Selection and in vitro and in vivo characterization of a Kunitz protease inhibitor domain of protease nexin 2 variant that inhibits factor XIa without inhibiting plasmin Eltringham-Smith LJ, Bhakta V, Sheffield WP 2021 J Biotechnol View Researchers Basic research
Five novel FY null alleles associated with typing discrepancies Vege S, Floch A, Lomas-Frances C, Clarke G, Westhoff CM 2021 Transfusion View Researchers Benchmarking and standard setting
Background incidence rates of hospitalisations and emergency department visits for thromboembolic and coagulation disorders in Ontario, Canada for COVID-19 vaccine safety assessment: a population-based retrospective observational study Nasreen S, Calzavara AJ, Sundaram ME, MacDonald SE, Righolt CH, Pai M, Field TS, Zhou LW, Wilson SE, Kwong JC 2021 BMJ Open View Researchers Clinical research
Plateletworks® as a Point-of-Care Test for ASA Non-Sensitivity Khan H, Jain S, Gallant RC, Syed MH, Zamzam A, Al-Omran M, Rand ML, Ni H, Abdin R, Qadura M 2021 J Pers Med View Researchers New or improved product or process
Chapter 2: Blood components Gupta A, Bigham M 2021 Clinical Guide to Transfusion View Health care providers Benchmarking and standard setting
Prevention of transfusion-transmitted syphilis by blood operators: How much is enough when transfusion-transmission has not been identified for decades? Drews SJ 2021 Transfusion View Blood operators Benchmarking and standard setting
Déclaration des réactions transfusionnelles indésirables Yan M 2021 Blood.ca website View Health care providers Benchmarking and standard setting
The impact of extended half-life factor concentrates on patient reported health outcome measures in persons with hemophilia A and hemophilia B Sun HL, Yang M, Poon MC, Lee A, Robinson KS, Sholzberg M, Wu J, Iorio A, Blanchette V, Carcao M, Klaassen RJ, Jackson S 2021 Res Pract Thromb Haemost View Researchers Clinical research
Implementation of measures to reduce vasovagal reactions: Donor participation and results Goldman M, Uzicanin S, Marquis-Boyle L, O'Brien SF 2021 Transfusion View Health care providers Clinical research
Combined preoperative plasma exchange and red blood cell exchange transfusion in a renal transplant patient with protein S deficiency and hemoglobin SC disease Cook O, Cervi A, Laureano M, Gangji AS, Verhovsek M 2021 Transfus Apher Sci View Researchers Clinical research
Concentré de recherche: Suggestion concernant le mécanisme en jeu dans la thrombocytopénie thrombotique induite par le vaccin Batarfi K 2021 Blood.ca website View Researchers Clinical research
Could antigen loss be a potential mechanism to explain antibody-mediated immune suppression? Cruz-Leal Y, Lazarus AH 2021 Transfusion View Researchers Basic research
Industry, experts and the role of the ‘invisible college’ in the dissemination of non-invasive prenatal testing in the US Holloway K, Miller FA, Simms N 2021 Soc Sci Med View Researchers Ethical, legal and social implications research
Circulaire d'information utilisation de composants sanguins humains: Cellules progénitrices hématopoïétiques de sang de cordon ombilical Stewart T 2021 Blood.ca website View Health care providers Benchmarking and standard setting
Improving Medical Education in Hematology and Transfusion Medicine in Canada: Standards and Limitations Laureano M, Mithoowani S, Tseng E, Zeller M 2021 Adv Med Educ Pract View Health care providers Benchmarking and standard setting
Chapter 16: Preoperative autologous donation Foster T, Yan M 2021 Clinical Guide to Transfusion View Health care providers Benchmarking and standard setting
Meta-Analysis of Risk of Vaccine-Induced Immune Thrombotic Thrombocytopenia Following ChAdOx1-S Recombinant Vaccine Chan BT, Bobos P, Odutayo A, Pai M 2021 medRxiv View Researchers Clinical research
The Effect of Sex-Mismatched Red Blood Cell Transfusion on Endothelial Cell Activation in Critically Ill Patients Alshalani A, van Manen L, Boshuizen M, van Bruggen R, Acker JP, Juffermans NP 2021 Transfus Med Hemotherapy View Researchers Clinical research
Circular of information for the use of human blood components: Plasma components Jenkins C 2021 Blood.ca website Health care providers Benchmarking and standard setting
A decision integration strategy for short-term demand forecasting and ordering for red blood cell components Li N, Chiang F, Down DG, Heddle NM 2021 Oper Res Health Care View Health care providers New or improved product or process
Potentially clinically significant anti-Dib identified by monocyte monolayer assay before transfusion Branch DR, Holton MB, Ison T, Cote J, Dube C, Lau W 2021 Transfusion View Researchers Basic research
Serotonin-release assay-positive but platelet factor 4-dependent enzyme-immunoassay negative: HIT or not HIT? Warkentin TE, Smythe MA, Ali MA, Aslam N, Sheppard JI, Smith JW, Moore JC, Arnold DM, Nazy I 2021 Am J Hematol View Researchers Clinical research
Non-invasive monitoring of red blood cells during cold storage using handheld Raman spectroscopy Vardaki MZ, Schulze HG, Serrano K, Blades MW, Devine DV, Turner RFB 2021 Transfusion View Researchers New or improved product or process
Lessons from vaccine-induced immune thrombotic thrombocytopenia Kelton JG, Arnold DM, Nazy I 2021 Nat Rev Immunol View Researchers Clinical research
Chapitre 6: Sélection des donneurs, dépistage des maladies transmissibles et réduction des agents pathogènes Drews S, Khandelwal A, Goldman M, Devine D 2021 Guide de la pratique transfusionnelle View Health care providers Benchmarking and standard setting
Dupilumab, severe asthma airway responses, and SARS-CoV-2 serology Bhalla A, Mukherjee M, Radford K, Nazy I, Kjarsgaard M, Bowdish DME, Nair P 2021 Allergy View Health care providers Basic research
Quality of evidence-based guidelines for platelet transfusion and use: A systematic review Al-Riyami AZ, Jug R, La Rocca U, Keshavarz H, Landry D, Shehata N, Stanworth SJ, Nahirniak S 2021 Transfusion View Researchers Benchmarking and standard setting
Themed issue – focusing on donor assessment, motivation and vigilance O’Brien SF, Ullum H, Seed CR 2021 Vox Sang View Researchers New or improved product or process
Adverse reactions reporting Yan M 2021 Blood.ca website View Health care providers Benchmarking and standard setting
Factor product utilization and health outcomes in patients with haemophilia A and B on extended half-life concentrates: A Canadian observational study of real-world outcomes Sun H, Yang M, Poon M-C, Lee A, Robinson KS, Sholzberg M, Wu J, Iorio A, Blanchette V, Carcao M, Klaassen RJ, Jackson S 2021 Haemophilia View Researchers Clinical research
Challenging the 30-min rule for thawed plasma Ramirez-Arcos S, Howell A, Bearne J, Bhakta V, Bower L, Cardigan R, Girard M, Kou Y, McDonald C, Nolin M-È, Sawicka D, Sheffield W 2021 Vox Sang View Researchers Benchmarking and standard setting
What constitutes the most cautious approach for a pregnant person with weak D type 4.0? Lieberman L, Flegel W, Bodnar M, Clarke G, Hannon J 2021 CMAJ Open View Health care providers Benchmarking and standard setting
How do I think about blood donor eligibility criteria for medical conditions? Goldman M 2021 Transfusion View Researchers Benchmarking and standard setting
ResearchUnit: A proposed mechanism for vaccine-induced thrombotic thrombocytopenia Batarfi K 2021 Blood.ca website View Researchers Clinical research
ABO blood group and COVID-19: a review on behalf of the ISBT COVID-19 working group Goel R, Bloch EM, Pirenne F, Al-Riyami AZ, Crowe E, Dau L, Land K, Townsend M, Jecko T, Rahimi-Levene N, Patidar G, Josephson CD, Arora S, Vermeulen M, Vrielink H, Montemayor C, Oreh A, Hindawi S, van den Berg K, Serrano K, So – Osman C, Wood E, Devine DV, Spitalnik SL, the ISBT COVID-19 Working Group 2021 Vox Sang View Researchers Clinical research
Evaluating the appropriateness of platelet transfusions compared with evidence-based platelet guidelines: An audit of platelet transfusions at 57 hospitals Hill-Strathy M, Pinkerton PH, Thompson TA, Wendt A, Collins A, Cohen R, WO BC, Cameron T, Lin Y, Lau W, Lieberman L, Callum J 2021 Transfusion View Health care providers Clinical research
Risk analysis of transfusion of cryoprecipitate without consideration of ABO group Hadjesfandiari N, Levin E, Serrano K, Yi Q-L, Devine DV 2021 Transfusion View Health care providers Benchmarking and standard setting
Circular of information for the use of human blood components: Hematopoietic Progenitor Cells (HPC) Cord Blood Stewart T 2021 Blood.ca website View Health care providers Benchmarking and standard setting
Clotting factor concentrates for preventing bleeding and bleeding-related complications in previously treated individuals with haemophilia A or B Olasupo OO, Lowe MS, Krishan A, Collins P, Iorio A, Matino D 2021 Cochrane Database Syst Rev View Health care providers Clinical research
Circular of information for the use of human blood components: Platelets Jenkins C 2021 Blood.ca website Health care providers Benchmarking and standard setting
FcgammaRI and FcgammaRIII on splenic macrophages mediate phagocytosis of anti-glycoprotein IIb/IIIa autoantibody-opsonized platelets in immune thrombocytopenia Norris PAA, Segel GB, Burack WR, Sachs UJ, Lissenberg-Thunnissen SN, Vidarsson G, Bayat B, Cserti-Gazdewich CM, Callum J, Lin Y, Branch D, Kapur R, Semple JW, Lazarus AH 2021 Haematologica View Researchers Basic research
Pragmatic, double-blind, randomised trial evaluating the impact of red blood cell donor sex on recipient mortality in an academic hospital population: the innovative Trial Assessing Donor Sex (iTADS) protocol Fergusson DA, Chassé M, Tinmouth A, Acker JP, English S, Forster AJ, Hawken S, Shehata N, Thavorn K, Wilson K, Tuttle A, Perelman I, Cober N, Maddison H, Tokessy M 2021 BMJ Open View Researchers Clinical research